Physician
Hematology
Dr. Arti Hurria, MD
|
|
Give Review
Arti Hurria practices Hematology. She studied medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care She has 1 awards "Regional Top Doctor". Arti Hurria is also a published doctor. She has 104 paper published. The most recent paper is: Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Szary syndrome.
Publications
- Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary St...
- Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
- Treatment of muscle invasive bladder Cancer in the elderly: navigating the trade-offs of risk and benefit.
- Anemia and Functional Disability in Older Adults With Cancer.
- Impact of care at comprehensive Cancer centers on outcome: Results from a population-based study.
- Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors.
- Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
- Age-Related Changes in Nanoparticle Albumin-Bound Paclitaxel Pharmacokinetics and Pharmacodynamics: Influence of Chronological Versus Functional Age.
- Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast Cancer.
- Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast Cancer.
- Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 ...
- Polypharmacy and Potentially Inappropriate Medication Use in Older Adults with Cancer Undergoing Chemotherapy: Effect on Chemotherapy-Related Toxicity and Hospitalizat...
- Breast Cancer and aging: results of the U13 conference breast Cancer panel.
- Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival.
- Screening tools for multidimensional health problems warranting a geriatric assessment in older Cancer patients: an update on SIOG recommendations.
- Factors associated with high burden in caregivers of older adults with Cancer.
- Cognitive impairment in older patients with breast Cancer before systemic therapy: is there an interaction between Cancer and comorbidity?
- Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901.
- Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast Cancer.
- The effect of aromatase inhibition on the cognitive function of older patients with breast Cancer.
- Underrepresentation of older adults in Cancer trials--reply.
- Occurrence of comorbidities among African-American and Latina breast Cancer survivors.
- Determining chemotherapy tolerance in older patients with Cancer.
- Cognitive effects of Cancer and its treatments at the intersection of aging: what do we know; what do we need to know?
- Improving the quality of Cancer care in an aging population: recommendations from an IOM report.
- A planned, prospective comparison of short-term quality of life outcomes among older patients with breast Cancer treated with standard chemotherapy in a randomized cli...
- Barriers to treatment in patients with locally advanced breast Cancer.
- CA125 level association with chemotherapy toxicity and functional status in older women with ovarian Cancer.
- Managing breast Cancer in the older patient.
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
- Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients.
- Elderly patients with colon Cancer have unique tumor characteristics and poor survival.
- Feasibility of computer-based self-administered Cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.
- Impact of a bilingual education intervention on the quality of life of Latina breast Cancer survivors.
- Factors influencing treatment patterns of breast Cancer patients age 75 and older.
- Follow-up care of breast Cancer survivors.
- Screening chest imaging studies are not effective in the follow-up of breast Cancer patients.
- Management of lung Cancer in older adults.
- Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast Cancer.
- Patterns of toxicity in older patients with breast Cancer receiving adjuvant chemotherapy.
- Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast Cancer receiving adjuvant chemotherapy.
- Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast Cancer.
- Developing a Cancer-specific geriatric assessment: a feasibility study.
- Effect of adjuvant breast Cancer chemotherapy on cognitive function from the older patient''s perspective.
- Cognitive function of older patients receiving adjuvant chemotherapy for breast Cancer: a pilot prospective longitudinal study.
- Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast Cancer: assessing outcome in a population-based, observational cohort.
- Geriatric assessment for oncologists: rationale and future directions.
- Do age and ethnicity predict breast Cancer treatment received? A cross-sectional urban population based study. Breast Cancer treatment: age and ethnicity.
- A prospective, longitudinal study of the functional status and quality of life of older patients with breast Cancer receiving adjuvant chemotherapy.
- Postmastectomy radiation and survival in older women with breast Cancer.
- Pharmacokinetics and toxicity of weekly docetaxel in older patients.
- Adjuvant treatment recommendations in older women with breast Cancer: a survey of oncologists.
- We need a geriatric assessment for oncologists.
- Pharmacokinetics of chemotherapy in the older patient.
- Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast Cancer?
- Clinical trials in older adults with Cancer: past and future.
- Comprehensive geriatric assessment for older patients with Cancer.
- Identifying vulnerable older adults with Cancer: integrating geriatric assessment into oncology practice.
- Renaming "chemobrain".
- Use of postmastectomy radiotherapy in older women.
- Incorporation of geriatric principles in oncology clinical trials.
- Management of breast Cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.
- Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group.
- NCCN Task Force Report: breast Cancer in the older woman.
- Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast Cancer.
- Functional assessment of the older patient with Cancer.
- Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast Cancer is feasible.
- Role of age and health in treatment recommendations for older adults with breast Cancer: the perspective of oncologists and primary care providers.
- Cancer in older adults: the oncologist's bread and butter.
- Cognitive effects of hormonal therapy in older adults.
- Adjuvant chemotherapy and hormonal therapy for older adults with breast Cancer.
- Geriatric assessment in older patients with breast Cancer.
- Future of Cancer incidence in the United States: burdens upon an aging, changing nation.
- Distress in older patients with Cancer.
- Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast Cancer: a survey of oncologists.
- Geriatric assessment in oncology practice.
- Evaluating the older patient with Cancer: understanding frailty and the geriatric assessment.
- Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast Cancer patients of varying age and health status.
- Polypharmacy in older adults with Cancer.
- Breast Cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
- Impact of age, sex, and comorbidity on Cancer therapy and disease progression.
- Geriatric oncology: past, present, future.
- Geriatric oncology field comes into its own: growing field advances but care questions remain.
- Studying Cancer-related fatigue: report of the NCCN scientific research committee.
- Implementing a geriatric assessment in cooperative group clinical Cancer trials: CALGB 360401.
- Aging and osteoporosis in breast and prostate Cancer.
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study.
- Systemic therapies for metastatic renal cell Carcinoma in older adults.
- Embracing the complexity of comorbidity.
- Second malignancies among elderly survivors of Cancer.
- Improvement in breast Cancer outcomes over time: are older women missing out?
- Senior adult oncology.
- Challenges in the management of older patients with colon Cancer.
- Treatment of non-small cell lung Cancer in the older patient.
- Research priorities in geriatric oncology: addressing the needs of an aging population.
- Early breast Cancer in the older woman.
- A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast Cancer.
- Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
- Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.
- ReCAP: ASCO Core Curriculum for Cancer Survivorship Education.
- Breast Cancer in Women Older Than 80 Years.
- Cancer and Aging: General Principles, Biology, and Geriatric Assessment.
Schools
Northwestern University Medical School
Beth Israel Medical Center
Beth Israel Deaconess Medical Center
Memorial SloanKettering Cancer Center
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Geriatric Medicine
- Medical Oncology
- Hematology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Beth Israel Deaconess Medical Center -
Northwestern University Feinberg School of Medicine
Hospital
-
City of Hope's Helford Clinical Research Hospital
Drug Facts
| NPI NUMBER | 1457322497 | |
| NPPES Provider LastName | HURRIA | |
| NPPES Provider FirstName | ARTI | |
| NPPES Provider ZIPCode | 910103012 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 768.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 35.0 | |
| Percent Opioid Claims | 4.56 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457322497 |
| Last Name Of The Provider | HURRIA |
| First Name Of The Provider | ARTI |
| View All |
Similar Doctors
|
Dr. Christina H. Yeon, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph Chao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amrita Krishnan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumanta K. Pal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pablo Parker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuan Yuan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathie T. Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thehang H. Luu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Rashmi Batra, MB
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sangeeta S. Awasthi, MD
This Doctor is OpenDoctor Recommended.
|